Chinese city orders real-name registration for chikungunya fever medication amid outbreak
chikungunya fever , while two cities in southeastern China have asked travellers returning from affected areas to monitor their health for signs of the mosquito-borne illness.
The market supervision bureau in Foshan,
Guangdong province issued a public notice on Sunday asking all retail pharmacies to start real-name registration and to keep records when selling medications to treat symptoms of chikungunya, including fever, rashes and joint pain.
This practice was also used during the Covid-19 pandemic to help mainland Chinese authorities track potential cases that were not reported.
Chikungunya fever is a viral disease transmitted by the Aedes mosquito. It cannot be contracted through direct contact with another person. While rarely fatal, the illness can lead to debilitating symptoms lasting weeks.
Those who buy the medications are required to provide their personal information and tell pharmacies about any recent mosquito bites or chikungunya symptoms, according to the notice.
Some health authorities in
Foshan have handed out administrative penalties for businesses that fail to promptly eliminate mosquito breeding sites, such as hotels and restaurants, according to state-run news site Southcn.com on Tuesday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
an hour ago
- South China Morning Post
Sunshine Lake Pharma falls in Hong Kong trading debut as market's IPO buzz takes a breath
Sunshine Lake Pharma's shares fell in their trading debut in Hong Kong, as the city's buzz over first-day trading took a breather while the stock market sought fresh directions from mainland China's macroeconomic statistics and trade talks. Advertisement Trading under the stock sign 6887, Sunshine's shares began trading at HK$57.50 on Thursday, a discount of 4.5 per cent to its initial public offer price of HK$60.24 in Hong Kong. Known also as Guangdong Dongyangguang Pharmaceutical, Sunshine is one of more than 50 drug companies that are looking to raise capital in Hong Kong, answering a drive by the bourse operator Hong Kong Exchanges and Clearing (HKEX), which has turned the city into the world's second-largest fundraising hub for pharmaceutical and medical research start-ups. 'The company will accelerate the integration of high-quality resources, speed up the commercialisation and globalisation of its innovative drug pipeline, and inject strong momentum into sustainable growth', Sunshine's chairman Zhang Yingjun said at the HKEX's Connect Hall, before striking a ceremonial gong to mark the commencement of trading. 'Our responsibility is heavy and the road is long, but we will dedicate ourselves to our chosen path. This listing is a new starting point for us. We will follow the path of hi-tech R&D and innovation to produce excellent medicines for patients and improve our performance to build a world-class pharmaceutical company.' Advertisement
South China Morning Post
4 hours ago
- South China Morning Post
To prevent the spread of chikungunya, public awareness is critical
Mosquitoes have long been a fact of life in subtropical Hong Kong and the focus of intense efforts to control the insects and diseases they carry. Such measures have been stepped up again this week with the first imported case of chikungunya fever since 2019. Recent heavy rain will inevitably boost mosquito populations. The public must support the fight by avoiding insect bites and working to remove standing water where mosquitoes breed. The first case in Hong Kong was confirmed on August 2 with a 12-year-old Kwun Tong boy contracting the disease, which is behind the outbreaks in mainland China. He had travelled with his mother to the Shunde district of Foshan in Guangdong province in late July and was bitten by mosquitoes there. Hong Kong authorities on Wednesday confirmed three new cases: a woman, 79, from Southern district who visited Foshan last month, and a 55-year-old man and his 10-year-old son, who live in Kwai Tsing district, who had travelled to Bangladesh between July 12 and August 3. Chikungunya fever's symptoms are similar to but milder than dengue fever. Symptoms can persist for months in high-risk individuals such as the elderly.
South China Morning Post
14 hours ago
- South China Morning Post
Hong Kong confirms 3 new imported cases of chikungunya fever
Hong Kong confirmed three new cases of chikungunya fever on Wednesday, comprising a woman returning from Guangdong province's Foshan and a father and son who had travelled to Bangladesh. The Centre for Health Protection on Wednesday said that it was investigating the three imported cases. Health authorities said the woman, 79, lived in Southern district and had visited the mainland Chinese city of Foshan from July 1 to 31 to see her relatives. The patient was unable to recall being bitten by a mosquito, but developed a fever and joint pain on Monday and sought treatment at Queen Mary Hospital in Pok Fu Lam the next day, the centre said. The other two cases are a 55-year-old man with a chronic disease and his 10-year-old son, who both live in Kwai Tsing district. The pair travelled to Bangladesh between July 12 and August 3. The father first developed symptoms in Bangladesh on July 27 and visited a clinic in Hong Kong on August 4.
